Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Revenues, Net Income Up for 1st Quarter

NEW YORK, May 7 – Venlo, Netherlands-based Qiagen announced today that its net revenues and net income were up for the first quarter ending March 31.

The company reported net sales of $80 million, compared to $70.5 million for the year-ago quarter. The firm had net income of $11 million, compared to $9.5 million for the same quarter in 2002.

The company took a first-quarter charge of $1.6 million for the closure of its Seattle facility in 2002 and reported current assets of $208 million as of March 31.

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.